Back
HFA Premium Access

Empagliflozin ameliorates post-infarction cardiac remodeling through overexpression of GTP enzyme cyclohydrolase 1

Session: Poster Session 2 - Basic Science - Metabolism
Topic: Drugs, Drug Targets
Speaker: Professor D. Pascual Figal (Murcia, ES)
Event: Heart Failure 2019

Congress Presentation

Add to my library

Like

About the speaker

Professor Domingo Pascual Figal

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)
5 presentations
1 follower

17 more presentations in this session

Basic Science - Metabolism - Poster Discussant - 10:00-11:00.

Access
Like
Thumbnail

Empagliflozin modulates GTP enzyme cyclohydrolase 1 in chronic heart failure

Speaker: Professor D. Pascual Figal (Murcia, ES)

Access
Abstract
Like
Thumbnail

The myocardial metabolism shift results to cardiomyocyte dedifferentiation in dilated cardiomyopathy and chronic heart failure.

Access
Like
Thumbnail

Pharmacological mitochondrial stabilization to prevents adverse cardiac remodeling following MI using empagliflozin

Speaker: Professor D. Pascual Figal (Murcia, ES)

Access
Abstract
Like
Thumbnail

Age-specific features of cardioprotective action of meldonium under the experimental severe hypoosomolar hyperhydration

Speaker: Doctor N. Demikhova (Sumy, UA)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 2 - Basic Science - Metabolism

Speakers: Professor D. Pascual Figal, Professor D. Pascual Figal, Professor D. Pascual Figal, Doctor N. Demikhova
Access
Like
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources